Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?

Regeneron Pharmaceuticals (NASDAQ: REGN) recently announced overwhelmingly positive results from a late-stage study of its antibody cocktail therapy in treating individuals infected with COVID-19. In this Motley Fool Live video recorded on March 24, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Regeneron's therapy could be as important as vaccines in the fight against COVID-19.